Disposable bioreactors could be the centerpiece of a project to develop and harvest large quantities of cells that eventually will be used in bioartificial livers for patients with severe liver failure.
Although it is widely acknowledged that medical bracelets can be the difference between life and death, Australia’s Nanotechnology Victoria (NanoVic) has become the first to take the idea further with its insulin-delivering jewellery project.
French firm Diatos has created a second generation irinotecan
cancer therapy using its patented peptide-based drug delivery
system, coming up with a drug that has greatly improved efficacy
and safety profile compared to current irinotecan...
The search for better models to predict drug-induced human liver
damage has led the FDA (US Food and Drug Administration) to turn to
Entelos to design a 'virtual liver' to guide biomarker and assay
A cell preservation solution that makes research using kidney cells
easier to carry out, developed by UK firm Abcellute, has been made
available on the Japanese market. Abcellute licensed Japanese
rights to the product to GeneFrontier,...
Researchers have, for the first time, identified two separate
populations of immune cells in the liver, which will help doctors
understand the mechanisms by which the liver is damaged and
repaired and may lead to future drug therapies.